Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | L611V |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | JAK2 L611V lies within the protein kinase domain 1 of the Jak2 protein (UniProt.org). L611V results in Jak2, Stat5, and Akt phosphorylation levels comparable to wild-type Jak2 in culture, however, L611V demonstrates constitutive activation of Jak2 when co-mutated with V617F (PMID: 20182460), and therefore, its effect on Jak2 protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 L611V |
Transcript | NM_004972.4 |
gDNA | chr9:g.5073752T>G |
cDNA | c.1831T>G |
Protein | p.L611V |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322196 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5073752T>G | c.1831T>G | p.L611V | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|